We are live on ! Find out more
JJ

Johnson & Johnson Portfolio holdings

AUM $799M
1-Year Est. Return 253.51%
This Fund
S&P 500
This Quarter Est. Return
-10.47%
1 Year Est. Return
+253.51%
3 Year Est. Return
+280.64%
5 Year Est. Return
+320.83%
10 Year Est. Return
–
AUM
$391M
AUM Growth
-$138M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
92.53%
Holding
22
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LEGN icon
1
Legend Biotech
LEGN
$3.93B
$89.6M 22.89%
1,629,173
– –
FATE icon
2
Fate Therapeutics
FATE
$294M
$83.7M 21.39%
3,379,064
– –
ARWR icon
3
Arrowhead Research
ARWR
$12.1B
$44.4M 11.34%
1,260,869
– –
PRCT icon
4
Procept Biorobotics
PRCT
$1.26B
$33.3M 8.51%
1,018,478
– –
MGTX icon
5
MeiraGTx Holdings
MGTX
$1.17B
$21.9M 5.61%
2,898,550
– –
CVRX icon
6
CVRx
CVRX
$78.3M
$21M 5.37%
3,495,575
– –
XNCR icon
7
Xencor
XNCR
$1.71B
$20.5M 5.23%
748,062
– –
PTGX icon
8
Protagonist Therapeutics
PTGX
$9.8B
$19.4M 4.95%
2,449,183
– –
HLTH
9
DELISTED
Cue Health Inc. Common Stock
HLTH
$17.8M 4.54%
5,548,864
– –
ACET icon
10
Adicet Bio
ACET
$77.3M
$10.6M 2.72%
45,559
– –
FUSN
11
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$9.14M 2.33%
3,670,516
– –
PNT
12
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$6.81M 1.74%
1,000,000
– –
VOR icon
13
Vor Biopharma
VOR
$1.38B
$5.34M 1.36%
53,733
– –
NNOX icon
14
Nano X Imaging
NNOX
$73.2M
$2.17M 0.56%
192,429
– –
ALDX icon
15
Aldeyra Therapeutics
ALDX
$86.9M
$1.57M 0.4%
394,834
– –
PHGE icon
16
BiomX
PHGE
$1.67M
$1.56M 0.4%
11,228
– –
SLGC
17
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$1.27M 0.32%
281,052
– –
PHAS
18
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$964K 0.25%
1,607,044
– –
TCON
19
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$168K 0.04%
4,200
– –
GYRE icon
20
Gyre Therapeutics
GYRE
$693M
$119K 0.03%
8,927
– –
SENS icon
21
Senseonics Holdings Inc
SENS
$409M
$56K 0.01%
2,731
– –
CALC icon
22
CalciMedica
CALC
$20.2M
$54K 0.01%
3,539
– –

Similar funds

HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
UM
Ulysses Management New York $802M AUM 5.35% 1-Year Est. Return
RIM
Redwood Investment Management Scottsdale, Arizona $805M AUM 15.01% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
AI
Aperture Investors New York $791M AUM 54.66% 1-Year Est. Return

Johnson & Johnson's Q2 2022 Portfolio in Review

As of Q2 2022, Johnson & Johnson held 22 positions worth $391M, down 26% from $529M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 0%. Johnson & Johnson opened no new positions and made no exits, leaving the 22-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Johnson & Johnson's ten largest holdings make up 93% of its $391M portfolio in Q2 2022.
  • Johnson & Johnson opened 0 new positions and closed 0 in Q2 2022.
  • Johnson & Johnson's portfolio value fell 26% quarter-over-quarter to $391M.

Based on Johnson & Johnson's 13F filing for Q2 2022, filed 10 Aug 2022.